Monday, 21 June 2010
PARI LC SPRINT: nebuliser of choice for clinical trials with inhaled antibiotic
The main advantage of inhaled antibiotic therapy is that the drug directly reaches the site of action and reduces adverse events for the entire organism. Recent results...
> more...

Monday, 21 June 2010
Comparison of four portable jet nebuliser systems: PARI BOY® mobile S performed best
In vitro tests revealed significant advantages of the lightweight PARI BOY® mobile S. Compared to the other systems, PARI BOY® mobile S produced more respirable...
> more...

Wednesday, 16 June 2010
See the PARI SINUS in action at the ECFC!
The nasopharyngeal cavity is of particular concern for CF patients as a possible portal of entry for pathogens. This is why a therapy with the PARI SINUS is of special...
> more...